21.57
price up icon1.27%   0.27
after-market Handel nachbörslich: 21.59 0.02 +0.09%
loading

Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
206.98%
0.264
0.086 - - -
Cost Of Revenue
6.81%
0.26
0.279 - - -
Gross Profit
102.07%
0.004
-0.193 - - -
Operating Expenses
9.50%
18.26
20.17 - - -
Benefits Costs and Expenses
741.58%
-131.22
20.45 - - -
Costs And Expenses
9.47%
18.52
20.45 20.27 18.04 20.26
Operating Income/Loss
10.38%
-18.25
-20.37 -20.27 -18.04 -20.26
Nonoperating Income/Loss
16.50%
0.82
0.982 1.107 1.249 0.876
Income/Loss From Continuing Operations Before Tax
745.58%
131.49
-20.37 -19.17 -16.80 -19.39
Income/Loss From Continuing Operations After Tax
761.07%
128.15
-19.39 -19.17 -16.80 -19.39
Net Income/Loss
10.07%
-17.43
-19.39 -19.17 -16.80 -19.39
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.80%
0.1323
67.39 67.28 67.13 1.229
Basic Earnings Per Share
10.34%
-0.26
-0.29 -0.28 -0.25 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$66.76
price up icon 0.97%
$164.23
price down icon 1.61%
medical_instruments_supplies COO
$69.92
price down icon 2.24%
$75.12
price down icon 0.12%
medical_instruments_supplies WST
$235.46
price up icon 1.89%
medical_instruments_supplies RMD
$230.84
price down icon 0.68%
Kapitalisierung:     |  Volumen (24h):